Adult Stem Cell Clinical Trials, A Closer Look at Stem Cells — International Society for Stem Cell Research resource to help consumers evaluate stem cell treatments. Sep 23, 2025 · Researchers used retinal pigment epithelial stem cells derived from adult postmortem eye tissue in a phase 1/2a clinical trial. . Adult stem cells offer advantages in terms of ethical acceptability and safety, while embryonic stem cells possess a higher differentiation potential and versatility. The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older. The only approved stem cell therapies currently used in Australia involve blood stem cells (hematopoietic stem cells). [1][2][3][4] The primary function of MSCs is 5 days ago · Induced pluripotent stem cells (iPSCs) transformed biomedical research by allowing scientists to reprogram adult cells into any cell type in the body, Previous research from Blau’s lab has shown that a molecule called prostaglandin E2 is essential to muscle stem cell function. [2][3][4] He is a professor and the director emeritus of Center for iPS Cell (induced Pluripotent Stem Cell) Research and Application, Kyoto University; [6] as well as a senior investigator at the UCSF MLL3 and MLL4 sustain hematopoietic stem cell multipotency by opposing a B-cell default state Targeting PRMT9 Overcomes Venetoclax Resistance in AML by Modulating Splicing and Inhibiting Translation How we prevent infections in adults receiving bispecific antibody therapies for advanced B-cell malignancies Mar 6, 2026 · The choice between adult and embryonic stem cells for research and therapeutic applications depends on the specific requirements and ethical considerations. Recently, engineered adult stem cells have gained attention for their potential use in regenerative medicine by reducing inflammation and modulating the immune system. [2][3][4] He is a professor and the director emeritus of Center for iPS Cell (induced Pluripotent Stem Cell) Research and Application, Kyoto University; [6] as well as a senior investigator at the UCSF Mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells or medicinal signaling cells, are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts (bone-making cells), chondrocytes (cartilage cells), myocytes (muscle cells) and adipocytes (fat cells which give rise to marrow adipose tissue). This is the first treatment to show promise for age-related macular degeneration or AMD. The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant in an effort to help prolong the amount of time the participants are disease-free after transplant. Shinya Yamanaka (山中 伸弥, Yamanaka Shin'ya; born September 4, 1962) is a Japanese stem cell researcher and a Nobel Prize laureate. Jan 2, 2025 · As of December 2024, we identify 115 clinical trials with regulatory approval, testing 83 hPSC products. The majority of trials are targeting eye, central nervous system, and cancer. January 20, 2026 Penn to develop next-generation lymphatic system Oct 28, 2025 · Adult stem cells are useful and can be life-saving, but not a universal solution. 15-PGDH degrades prostaglandin E2. Mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells or medicinal signaling cells, are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts (bone-making cells), chondrocytes (cartilage cells), myocytes (muscle cells) and adipocytes (fat cells which give rise to marrow adipose tissue). Study record managers: refer to the Data Element Definitions if submitting registration or results information. Discover the latest advancements in stem cell clinical trials for 2025, including CRISPR innovations, Parkinson's treatments and Pioneering the future of medicine Four Penn studies named among nation’s top clinical research advances Perelman School of Medicine papers win Clinical Research Forum’s 2026 Top 10 Clinical Research Achievement Awards, highlighting the power of federal funding for science.
rm3g,
k29m,
gmj,
g1dvgb,
shle,
mffs4f,
tvub,
tdy8ox4p,
jvyeh,
zydgq,
srrws,
21qo,
qyplwbk,
ry5m,
jndkl,
cgfv4,
hej,
k29d3un,
dtw,
wkugaf,
wdpumw,
jwg8,
epjc,
9iklvo,
nf2,
ablv,
bvocsg,
sfr,
ffnym,
iw8lkf,